5-amino-N-methylnaphthalene-1-sulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 5-amino-N-methylnaphthalene-1-sulfonamide
• 化学式: C₁₁H₁₂N₂O₂S
• 分子量: 236.29
• InChiKey: GMGBBEYNXBOJCJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• HIV REPLICATION INHIBITOR
  申请人：Shionogi & Co., Ltd.

  公开号：US20140249306A1

  公开（公告）日：2014-09-04

  The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. wherein, a broken line means the presence or absence of a bond; R 1 is substituted or unsubstituted alkyl etc., R 2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R 3 is a substituted or unsubstituted aromatic carbocyclic group; R 4 is a hydrogen atom etc.; R 5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R 6 is substituted or unsubstituted alkyl; R 7 is —Z—R 71 etc.; Z is —NR 72 —CO— etc.; R 71 is substituted or unsubstituted alkyl etc.; R 72 is a hydrogen atom etc.

  本发明提供了一种具有抗病毒作用的新化合物，特别是具有抑制HIV复制作用的化合物，以及一种药物组合物，特别是一种抗HIV药物。其中，虚线表示键的存在或不存在；R1是取代或未取代的烷基等，R2是取代或未取代的烷氧基等；n为1或2；R3是取代或未取代的芳香环烷基；R4是氢原子等；R5是取代或未取代的芳香环烷基等；Y是单键等；R6是取代或未取代的烷基；R7是—Z—R71等；Z是—NR72—CO—等；R71是取代或未取代的烷基等；R72是氢原子等。
• Nitrosation-Inducible Inhibitors Biological Macromolecules
  申请人：NUDLER Evgeny

  公开号：US20090186829A1

  公开（公告）日：2009-07-23

  Biomacromolecules such as proteins are inactivated by hydrophobic ANSA derivatives of the formula: wherein R 1 and R 2 are hydrophobic or affinity groups and R 3 is selected from the group consisting of aminoacyl groups and peptidyl groups upon nitrosation. ANSA derivatives can be designed to selectively kill tumor cells and various pathogens, including bacteria, viruses, and fungi.
• US9199959B2
  申请人：——

  公开号：US9199959B2

  公开（公告）日：2015-12-01
• [EN] QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST<br/>[FR] QUINAZOLIN-2,4-DIAZIRINES EN TANT QU'ANTAGONISTE DU RECEPTEUR DU NEUROPEPTIDE Y
  申请人：NOVARTIS AG

  公开号：WO1997020822A1

  公开（公告）日：1997-06-12

  (EN) The invention relates to a method of treatment of disorders and diseases associated with NPY receptor subtype Y5 comprising administering to a warm-blooded animal, including man, in need of such treatment a therapeutically effective amount of a compound of formula (I), in which the variables are as defined and relates to new compounds of formula (I) or a salt thereof, to pharmaceutical compositions, and to the manufacture of new compounds of formula (I) and salts thereof.(FR) L'invention concerne une méthode de traitement de troubles et maladies associés au sous-type Y5 du récepteur du neuropeptide Y, laquelle consiste à administrer à un animal à sang chaud nécessitant un tel traitement, et notamment à l'homme, une dose efficace sur le plan thérapeutique d'un composé de la formule (I) dans laquelle les variables sont telles que définies. L'invention concerne également des nouveaux composés de la formule (I) ou un sel de ceux-ci, des compositions pharmaceutiques ainsi que la fabrication de ces nouveaux composés et des sels de ceux-ci.